Search Results - "Pálfí, Anikó" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

HDP-101, an Anti-BCMA Antibody-Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells

HDP-101, an Anti-BCMA Antibody-Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells

by Figueroa-Vazquez, Vianihuini, Ko, Jonathan, Breunig, Christian, Baumann, Anja, Giesen, Nicola, Pálfi, Anikó, Müller, Christoph, Lutz, Christian, Hechler, Torsten, Kulke, Michael, Müller-Tidow, Carsten, Krämer, Alwin, Goldschmidt, Hartmut, Pahl, Andreas, Raab, Marc S
Published in Molecular cancer therapeutics (01.02.2021)

Get full text

Journal Article

A three component mix of thioredoxin-L2 antigens elicits broadly neutralizing responses against oncogenic human papillomaviruses

A three component mix of thioredoxin-L2 antigens elicits broadly neutralizing responses against oncogenic human papillomaviruses

by Seitz, Hanna, Canali, Elena, Ribeiro-Müller, Lis, Pàlfi, Anikó, Bolchi, Angelo, Tommasino, Massimo, Ottonello, Simone, Müller, Martin
Published in Vaccine (07.05.2014)

Get full text

Journal Article

Abstract 1761: Treatment with antibody-targeted amanitin conjugates induces tolerability in preclinical models without triggering tolerance

Abstract 1761: Treatment with antibody-targeted amanitin conjugates induces tolerability in preclinical models without triggering tolerance

by Decker, Kristin, Schmitt, Marisa, Araman, Can, Ebeling, Franziska, Dranova, Irina, Hechler, Torsten, Pálfí, Anikó, Pahl, Andreas, Kulke, Michael
Published in Cancer research (Chicago, Ill.) (15.06.2022)

Get full text

Journal Article

Abstract 237: Preclinical evaluation of anti-HER2 Antibody Targeted Amanitin Conjugates (ATACs) on HER2low breast cancer with chromosome 17p deletion

Abstract 237: Preclinical evaluation of anti-HER2 Antibody Targeted Amanitin Conjugates (ATACs) on HER2low breast cancer with chromosome 17p deletion

by Breunig, Christian, Pálfi, Anikó, Kulke, Michael, Lutz, Christian, Müller, Christoph, Hechler, Torsten, Pahl, Andreas
Published in Cancer research (Chicago, Ill.) (01.07.2019)

Get full text

Journal Article

Abstract 740: Preclinical evaluation of an anti-PSMA antibody-targeted amanitin conjugate (ATAC)

Abstract 740: Preclinical evaluation of an anti-PSMA antibody-targeted amanitin conjugate (ATAC)

by Pálfi, Anikó, Breunig, Christian, Hechler, Torsten, Müller, Christoph, Lutz, Christian, Pahl, Andreas, Kulke, Michael
Published in Cancer research (Chicago, Ill.) (01.07.2018)

Get full text

Journal Article

Abstract 735: SAR of amanitin and optimization of linker-amanitin derivatives for solid tumors

Abstract 735: SAR of amanitin and optimization of linker-amanitin derivatives for solid tumors

by Kulke, Michael, Pálfi, Anikó, Müller, Christoph, Simon, Werner, Werner-Simon, Susanne, Lutz, Christian, Hechler, Torsten, Pahl, Andreas
Published in Cancer research (Chicago, Ill.) (01.07.2018)

Get full text

Journal Article

Abstract 2636: Amanitin-based ADCs targeting Guanylyl cyclase C (GCC) as novel therapeutic modality for treatment of colorectal cancer

Abstract 2636: Amanitin-based ADCs targeting Guanylyl cyclase C (GCC) as novel therapeutic modality for treatment of colorectal cancer

by Braun, Alexandra, Pelz, Andreas, Ebeling, Franziska, Decker, Kristin, Pálfi, Anikó, Kulke, Michael, Pahl, Andreas, Hechler, Torsten
Published in Cancer research (Chicago, Ill.) (04.04.2023)

Get full text

Journal Article

Abstract 1523: Subcutaneous dosing of amatoxin-based ADCs increases the therapeutic index

Abstract 1523: Subcutaneous dosing of amatoxin-based ADCs increases the therapeutic index

by Decker, Kristin, Vranic, Marija, Schmitt, Marisa, Dranova, Irina, Pálfi, Anikó, Hechler, Torsten, Pahl, Andreas, Kulke, Michael
Published in Cancer research (Chicago, Ill.) (04.04.2023)

Get full text

Journal Article

Abstract 1865: HDP-102 - a CD37-targeting Amanitin-based-ADC for the treatment of NHL - non-clinical data package

Abstract 1865: HDP-102 - a CD37-targeting Amanitin-based-ADC for the treatment of NHL - non-clinical data package

by Neuberth, Sarah-Jane, Decker, Kristin, Orlik, Christian, Dranova, Irina, Pálfi, Anikó, Hechler, Torsten, Pahl, Andreas, Kulke, Michael
Published in Cancer research (Chicago, Ill.) (22.03.2024)

Get full text

Journal Article

Abstract 1754: Amatoxin-based antibody-drug conjugates induce immunogenic cell death and improve the anti-tumor efficacy of immune checkpoint inhibitors in humanized mouse models

Abstract 1754: Amatoxin-based antibody-drug conjugates induce immunogenic cell death and improve the anti-tumor efficacy of immune checkpoint inhibitors in humanized mouse models

by Orlik, Christian, Ebeling, Franziska, Decker, Kristin, Dranova, Irina, Pálfi, Anikó, Mueller, Christoph, Hechler, Torsten, Pahl, Andreas, Kulke, Michael
Published in Cancer research (Chicago, Ill.) (15.06.2022)

Get full text

Journal Article

HDP-101: Preclinical evaluation of a novel anti-BCMA antibody drug conjugates in multiple myeloma

HDP-101: Preclinical evaluation of a novel anti-BCMA antibody drug conjugates in multiple myeloma

by Pahl, Andreas, Ko, Jonathan, Breunig, Christian, Figueroa, Vianiuhini, Lehners, Nicola, Baumann, Anja, Pálfi, Anikó, Mueller, Christoph, Lutz, Christian, Hechler, Torsten, Kulke, Michael, Mueller-Tidow, Carsten, Goldschmidt, Hartmut, Raab, Marc
Published in Journal of clinical oncology (20.05.2018)

Get full text

Journal Article

ETx-22: a novel nectin-4-directed antibody drug conjugate, demonstrates safety and potent antitumor activity in low nectin-4 expressing tumors

ETx-22: a novel nectin-4-directed antibody drug conjugate, demonstrates safety and potent antitumor activity in low nectin-4 expressing tumors

by Lopez, Marc, Crompot, Emerence, Josselin, Emmanuelle, Farina, Anne, Rubis, Marion, Castellano, Remy, Fares, Joanna, Wehbe, Maria, Collette, Yves, Charafe-Jauffret, Emmanuelle, Blanchin, Stéphanie, Romagne, Francois, Pálfi, Anikó, Hechler, Torsten, Pahl, Andreas, Azim, Hatem A, Lhospice, Florence, Mamessier, Emilie, Bertucci, François, Elands, Jack, Preville, Xavier, Olive, Daniel
Published in Cancer research communications (23.10.2024)

Get full text

Journal Article

Abstract 915: Preclinical evaluation of anti-CD37 antibody-targeted amanitin conjugates (ATAC) in B-cell malignancies

Abstract 915: Preclinical evaluation of anti-CD37 antibody-targeted amanitin conjugates (ATAC) in B-cell malignancies

by Voss, Stephanie, Palfi, Aniko, Mueller, Christoph, Pahl, Andreas, Hechler, Torsten, Kulke, Michael
Published in Cancer research (Chicago, Ill.) (01.07.2021)

Get full text

Journal Article

Abstract 910: Amanitin-based ADCs targeting PSMA as novel therapeutic modality for prostate cancer therapy

Abstract 910: Amanitin-based ADCs targeting PSMA as novel therapeutic modality for prostate cancer therapy

by Braun, Alexandra, Palfi, Aniko, Mueller, Christoph, Hechler, Torsten, Pahl, Andreas, Kulke, Michael
Published in Cancer research (Chicago, Ill.) (01.07.2021)

Get full text

Journal Article

Abstract 921: Combination of antibody-targeted amanitin conjugates (ATAC) with immune checkpoint inhibitors shows synergistic therapeutic effect in vitro and in vivo

Abstract 921: Combination of antibody-targeted amanitin conjugates (ATAC) with immune checkpoint inhibitors shows synergistic therapeutic effect in vitro and in vivo

by Decker, Kristin, Dranova, Irina, Orlik, Christian, Palfi, Aniko, Mueller, Christoph, Singh, Ram Kumar, Orlowski, Robert Z., Hechler, Torsten, Pahl, Andreas, Kulke, Michael
Published in Cancer research (Chicago, Ill.) (01.07.2021)

Get full text

Journal Article

Abstract 2973: CD269 - A promising target for amanitin based ADCs

Abstract 2973: CD269 - A promising target for amanitin based ADCs

by Palfi, Aniko, Hechler, Torsten, Mueller, Christoph, Pahl, Andreas, Kulke, Michael
Published in Cancer research (Chicago, Ill.) (15.07.2016)

Get full text

Journal Article

Abstract LB059: Multimeric linker-exatecan-based ADC targeting guanylyl cyclase C (GCC) as novel therapeutic modality for treatment of colorectal cancer

Abstract LB059: Multimeric linker-exatecan-based ADC targeting guanylyl cyclase C (GCC) as novel therapeutic modality for treatment of colorectal cancer

by Neuberth, Sarah-Jane, Orlik, Christian, Palfi, Aniko, Mueller, Christoph, Gruss, Hendrik, Hechler, Torsten
Published in Cancer research (Chicago, Ill.) (05.04.2024)

Get full text

Journal Article

Abstract 77: Preclinical evaluation of HDP-101, an anti-BCMA antibody-drug conjugate

Abstract 77: Preclinical evaluation of HDP-101, an anti-BCMA antibody-drug conjugate

by Hechler, Torsten, Palfi, Aniko, Müller, Christoph, Lutz, Christian, Pahl, Andreas, Kulke, Michael
Published in Cancer research (Chicago, Ill.) (01.07.2017)

Get full text

Journal Article

Abstract 62: CD19 - a potential target for Amanitin-based ADCs

Abstract 62: CD19 - a potential target for Amanitin-based ADCs

by Hechler, Torsten, Palfi, Aniko, Müller, Christoph, Lutz, Christian, Pahl, Andreas, Kulke, Michael
Published in Cancer research (Chicago, Ill.) (01.07.2017)

Get full text

Journal Article

AMANITIN ANTIBODY CONJUGATES

AMANITIN ANTIBODY CONJUGATES

by LUTZ, Christian, MÜLLER, Christoph, KULKE, Michael, PÁLFI, Anikó, HECHLER, Torsten, PAHL, Andreas, SIMON, Werner
Year of Publication 09.10.2024

Get full text

Patent